Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

Taispeáin leaganacha eile (1)

Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Read, R, Baxter, D, Chadwick, DR, Faust, SN, Finn, A, Gordon, S, Heath, P, Lewis, D, Pollard, A, Turner, D, Bazaz, R, Ganguli, A, Havelock, T, Neal, K, Okike, I, Morales-Aza, B, Patel, K, Snape, MD, Williams, J, Gilchrist, S, Gray, S, Maiden, M, Toneatto, D, Wang, H, McCarthy, M
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: Lancet 2014
Cur síos
Achoimre:Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18-24-year-olds.

Míreanna comhchosúla